ATP-DEPENDENT C-TERMINAL MODIFICATION OF POLYPEPTIDES

CYSTEINE PROTOTROPHY

TREATMENT FOR METHAMPHETAMINE CARDIOVASCULAR DISEASE

Method of improving methyltransferase activity

ENGINEERED BIOSYNTHETIC PATHWAYS FOR PRODUCTION OF CYSTATHIONINE BY FERMENTATION

METHODS OF DIAGNOSING AND TREATING MULTIPLE SCLEROSIS WITH VASCULAR ENDOTHELIAL BIOMARKERS

GENETIC MARKER FOR HELICOBACTER PYLORIASSOCIATED DISEASE

Treatment for methamphetamine cardiovascular disease

Human-enzyme mediated depletion of homocysteine for treating patients with hyperhomocysteinemia and homocystinuria

Engineered primate cystine/cysteine degrading enzymes for therapeutic uses

Antimalarial enzyme conjugates, kits containing same, and methods of producing and using same

Engineered primate cystine/cysteine degrading enzymes as antineogenic agents

Engineered primate cystine/cysteine degrading enzymes as antineogenic agents

Engineered primate L-methioninase for therapeutic purposes

THERAPEUTIC CELL SYSTEMS AND METHODS FOR TREATING HOMOCYSTINURIA

Method of improving methyltransferase activity

Engineered primate cystine/cysteine degrading enzymes for therapeutic uses

Human-enzyme mediated depletion of homocysteine for treating patients with hyperhomocysteinemia and homocystinuria

SYNTHETIC CARBON FIXATION PATHWAYS

Engineered primate L-methioninase for therapeutic purposes

ISOLATED ENZYMATIC MANUFACTURE OF SEMICONDUCTOR NANOPARTICLES

Engineered primate L-methioninase for therapeutic purposes

SCHIFF-BASE CONJUGATE OF N, N-DIBUTYL-P-PHENYLENEDIAMINE WITH PYRIDOXAL 5'-PHOSPHATE FOR IMPROVED HOMOCYSTEINE ASSAYS USING PYRIDOXAL 5'-PHOSPHATE-DEPENDENT ENZYMES

Stringent selectable markers

Enzyme conjugate and prodrug cancer therapy

METHIONINE METABOLITES PREDICT AGGRESSIVE CANCER PROGRESSION

Engineered primate cystine/cysteine degrading enzymes as antineogenic agents

Engineered primate L-methioninase for therapeutic purposes

Stringent selectable markers